In October 2021, FDA announced the approval of Tyrvaya, a first-inclass medication to treat the signs and symptoms of dry eye disease.
Johanna Taylor Katroscik, PharmD
According to a 2019 Brain Health and Dietary Supplements Survey conducted by AARP, over 25% of Americans age 50 and up use some sort of supplement to help boost their brain health.
Welcome to 2022! As we continue to navigate stressful and uncertain times, an issue such as insomnia—normally a fairly common complaint— will become even more prevalent.
Daniel L. Krinsky, BS, MS, RPh, FAPhA
Updates from FDA
APhA Staff
In the ongoing aftermath of the opioid crisis, it’s common for physicians to attempt to wean some patients off of opioids in favor of alternative means of pain management.
Sonya Collins